毛彦稳,张小欢,刘玲伶,刘慧铭,梁露群,张会芳,向珈谊,王圆圆
MAO Yanwen,ZHANG Xiaohuan,LIU Lingling,LIU Huiming,LIANG Luqun,ZHANG Huifang,XIANG Jiayi,WANG Yuanyuan

• 1:贵州医科大学基础医学院病理生理教研室贵州省常见慢性疾病发病机制及药物研究重点实验室

摘要(Abstract)：

目的:观察高糖条件下Smad3对肾小管上皮细胞转分化的影响,探讨Smad3在高糖诱导肾脏纤维化中的作用。方法:将体外培养的肾小管上皮细胞分为正常糖组(NG组)、高糖组(HG组),Western blot鉴定细胞表型(E-cadherin及Desmin蛋白)及对高糖刺激后表型蛋白的变化;Western blot和Real-time PCR验证敲低Smad3质粒(Smad3-sh)、过表达Smad3质粒(OE-Smad3)转染肾小管上皮细胞细胞后Smad3蛋白及mRNA表达水平;分别在NG和HG条件下敲低或过表达肾小管上皮细胞Smad3蛋白,采用Western blot检测Smad3、p-Smad3、E-cadherin及Desmin蛋白表达水平。结果:NG组E-cadherin蛋白高表达,而Desmin表达较少;与NG组比较,HG刺激后E-cadherin蛋白表达显著减少(P<0.05),Desmin蛋白表达显著增加(P<0.05);敲低肾小管上皮细胞中Smad3后,E-cadherin蛋白表达显著增加(P<0.05),Desmin蛋白表达显著减少(P<0.05);过表达肾小管上皮细胞中Smad3后,E-cadherin蛋白表达显著减少(P<0.05),Desmin蛋白表达显著增加(P<0.05)。结论:Smad3能促进HG诱导肾小管上皮细胞转分化过程,从而促进高糖介导的纤维化发生。
Objective: To observe the effect of high glucose(HG)-mediated Smad3 expression on renal tubular epithelial cell transdifferentiation and explore the role of Smad3 expression in high glucose-induced renal fibrosis. Methods: Renal tubular epithelial cells were grew in media supplemented with normal glucose(NG group) and HG(HG group), respectively. Western blot was used to assess the protein expression levels. The mRNA expression levels of genes was assessed by real-time PCR. Smad3-shRNA(Smad3-sh) plasmid and Smad3-expressing plasmid were transfected to inhibit and overexpress Smad3 in renal tubular epithelial cells, respectively. Results: Relative to NG group, HG treatment remarkably downregulated E-cadherin expression(P<0.05), but upregulated Desmin(P<0.05). Knockdown of Smad3 increased E-cadherin expression level(P<0.05) and decreased Desmin expression level(P<0.05), while overexpressing Smad3 reversed Smad knockdown-mediated effect on E-cadeherin and Desmin. Conclusion: Smad3 can promote the HG-mediated transdifferentiation of renal tubular epithelial cells, which leads to fibrosis.

关键词(KeyWords)： 糖尿病肾病;高糖;Smad3;肾小管上皮细胞;上皮细胞转分化;肾脏纤维化
diabetic nephropathy;high glucose;Smad3;renal tubular epithelial cells;epithelial cell transdifferentiation;renal fibrosis

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金(81760131)

作者(Author): 毛彦稳,张小欢,刘玲伶,刘慧铭,梁露群,张会芳,向珈谊,王圆圆
MAO Yanwen,ZHANG Xiaohuan,LIU Lingling,LIU Huiming,LIANG Luqun,ZHANG Huifang,XIANG Jiayi,WANG Yuanyuan

DOI: 10.19367/j.cnki.1000-2707.2019.12.006

参考文献(References)：

• [1] DU M R,JU G X,LI N S,etal.Role of asymmetrical dimethylarginine in diabetic microvascular complications[J].J Cardiovasc Pharmacol,2016,68(4):322-326.
• [2] HUANG K H,GUAN S S,LIN W H,etal.Role of Calbindin-D28k in diabetes-associated advanced glycation End-products-induced renal proximal tubule cell injury[J].Cells,2019,30(7):660-676.
• [3] RAVINDRA N S,PASHAM,AGOUNIA,etal.Microparticles as potential mediators of high glucose-induced renal cell injury[J].Biomolecules,2019,9(8):348-362.
• [4] KATO M,NATARAJANR.Diabetic nephropathy--emerging epigenetic mechanism[J].Nat Rev Nephrol,2014,10(9):517-530.
• [5] WANG Y,LIU L,PENG W,et al.Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression[J].J Cell Physiol,2019,234(10):17925-17936.
• [6] 曾令萍,肖瑛,张莹莹,等.BMP-7对高糖环境下肾小管上皮细胞Id2和E2A蛋白表达的影响[J].中国病理生理杂志,2016,2:321-326.
• [7] LIU L,WANG Y,YAN R,et al.BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation[J].Life Sci,2019,238:116957-116968.
• [8] 毛彦稳,张小欢,刘慧铭,等.硫辛酰胺对高糖条件下肾小管上皮细胞氧化应激及转化生长因子β激活酶1和核转录共抑制因子蛋白表达的影响[J].实用医学杂志,2019,35(19),2993-3003.
• [9] HU H H,CHEN D Q,WANG Y N,et al.New insights into TGF-β/Smad signaling in tissue fibrosis[J].Chem Biol Interact,2018,292:76-83.
• [10]ZHOU Y,HUANG F,LIU Y,et al.TGF-β1 relieves epithelial-mesenchymal transition reduction in hypospadias induced by DEHP in rats[J].Pediatr Res,2019,19:622-629.
• [11]CHANG A S,HATHAWAY C K,SMITHIES O,etal.Transforming growth factor-β1 anddiabetic nephropathy[J].Am J Physiol Renal Physiol,2016,310(8):689-696.
• [12]ZHANG L,LIU C,MENG X M,et al.Smad2 protects against TGF-β1/Smad3-mediated Collagen synthesis in human hepatic stellate cells during hepaticfibrosis[J].Mol Cell Biochem,2015,400(1-2):17-28.
• [13]MENG X M,HUANG X R,CHUNG A C,et al.Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis[J].J Am Soc Nephrol,2010,21(9):1477-1487.
• [14]MENG X M,NIKOLIC-PATERSON D J,LAN H Y.TGF-beta:the master regulator of fbrosis[J].NatRev Nephrol,2016,12(6):325-338.
• [15]HUYNH P,CHAI Z.Transforming growth factor β(TGFβ) and related molecules in chronic kidney disease (CKD)[J].ClinSci,2019,133(2):287-313.
• [16]LAN H Y.Diverse roles of TGF-β/Smads in renal fibrosis and inflammation[J].Int J Biol Sci,2011,7(7):1056-1067.
• [17]WU C,CHEN W,FANG M,et al.Compound astragalus and salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated smad3 phosphorylation[J].J Ethnopharmacol,2019,231:98-112.
• [18]HUANG X,YUE Z,WU J,et al.MicroRNA-21 knockout exacerbates angiotensin II-induced thoracic aortic aneurysm and dissection in mice with abnormal transforming growth factor-β-SMAD3 signaling[J].Arterioscler Thromb Vasc Biol,2018,38:1086-1101.
• [19]ZHU Q,PEARSONWHITE S,LUO K.Requirement for the SnoNoncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells[J].Mol Cell Biol,2005,25(24):10731-10744.
• [20]ZHANG X,EGAWA K,XIEY,etal.The expression of SnoN in normal human skin and cutaneous keratinous neoplasms[J].Int J Dermatol,2009,48:579-583.
• [21]WANG Y,MAO Y,ZHANG X,et al.TAK1 may promote the development of diabetic nephropathy by reducing the stability of SnoN protein[J].Life Sci,2019,228:1-10.

文章评论(Comment)：